Hengrui Pharma (01276) has issued an announcement regarding the progress of its share repurchase program.

As of July 19, 2026, the company has cumulatively repurchased 13,750,200 of its A-shares through the centralized competitive bidding system of the Shanghai Stock Exchange.

The repurchased shares represent approximately 0.21% of the company's total share capital.

The highest price paid per share was RMB 70.00, while the lowest price was RMB 45.30.

The total amount paid for the repurchased shares was RMB 853 million, excluding transaction fees.